Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Bonus Biogroup Ltd

+ Add to Watchlist

BONS:IT

55.30 ILs 0.70 1.25%

As of 10:39:28 ET on 05/28/2015.

Snapshot for Bonus Biogroup Ltd (BONS)

Open: 57.00 Day's Range: 55.00 - 57.00 Volume: 842,062
Previous Close: 56.00 52wk Range: 21.30 - 64.00 1-Yr Rtn: +134.32%

Stock Chart for BONS

No chart data available.
  • BONS:IT 55.30
  • 1D
  • 1M
  • 1Y
56.00
Interactive BONS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BONS

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. TA-100 -
Earnings Per Share (ttm) -0.0440
Est. EPS -
Est. PEG Ratio -
Market Cap (M ILS) 115.80
Shares Outstanding (M) 209.41
30 Day Average Volume 2,960,058
Price/Book (mrq) 92.2117
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BONS

  • Revenue
  • Net Income (M/ILS)
  • Profit Margin (%)

Company Profile & Key Executives for BONS

Bonus BioGroup Ltd is an an Israeli biotechnology company. The Company is focused on growing new healthy bone from stem cells harvested from the patient's own fat. Bonus Biogroup is targeting the worldwide market for the treatment of major disorders such as bone and cartilage related arthritis and osteoporosis.

Shai MeretzkiCEO/PresidentYoni LivneChief Financial Officer
Aharon MichaelyInternal Auditor
More Company Profile & Key Executives for BONS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil